Potential Effect of Vortioxetine on Restless Leg Syndrome

Area of Science:

• Neurology
• Psychiatry

Background:

• Restless Legs Syndrome (RLS) is a progressive neurological disorder often co-occurring with anxiety and depression.
• Certain antidepressants, like SSRIs and SNRIs, are known to exacerbate RLS symptoms.
• Vortioxetine, an antidepressant, has no documented adverse effects on RLS.

Observation:

• This case series investigated vortioxetine's effect on RLS in 7 patients experiencing depression and anxiety.
• Patients with RLS and comorbid depression/anxiety were treated with vortioxetine.

Findings:

• Adding vortioxetine to treatment led to symptom regression in 5 out of 7 patients.
• No separate medication for RLS was required in the majority of patients who improved.
• This suggests vortioxetine may have a beneficial effect on RLS symptoms.

Implications:

• Vortioxetine shows potential as a treatment option for restless legs syndrome in patients with comorbid mood disorders.
• Further randomized controlled trials are necessary to confirm the efficacy and safety of vortioxetine for RLS.
• This research highlights the need to consider antidepressant side effect profiles in managing complex patient conditions.